Share these talks and lectures with your colleagues
Invite colleaguesWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Conflicts of interest
- Learning objectives
- Benefits of clear asthma management strategy
- GINA 2006: levels of asthma control (1)
- Asthma management continuum
- Asthma control in Canada
- GINA 2006: levels of asthma control (2)
- Simplified management based upon control
- Initial treatment in mild asthma
- Early intervention with budesonide
- Compliance to ICS therapy can prevent deaths
- Exacerbations requiring oral steroids
- Initial treatment of asthma
- Add-on therapies
- The risk:benefit ratios of ICS
- Available ICS + LABA single-inhaler combinations
- Well controlled asthma with sustained treatment
- The STAY study
- STAY: study design
- SMART increased time to severe exacerbation
- Severe exacerbations
- Need for systemic steroids
- MF/F therapy delayed time to deterioration
- Asthma control: current control and future risk
- JACI 2010 - design
- JACI 2010 - results
- Fixed dose versus SMART
- Exacerbations and sputum eosinophil counts
- Sputum eosinophil counts: RCT design
- Current control and future risk
- A window of opportunity
- The people in your practice
- Many switched/discontinued maintenance therapy
- Acute treatment for asthma in past year
- Stopped taking controller in past year
- Attitudes about asthma and its treatment
- Actual and perceived asthma control
- Family physicians' knowledge of asthma control
- Asthma control: a comprehensive concept
- Strategies to engage patients for better control
- Asthma exacerbations increase future risk
- Future exacerbations and recent exacerbations
- Asthma exacerbations association with costs
- Lung function by asthma and smoking status
- Factors contributing to airway remodeling
- Loss of lung function and severe exacerbations
- Anti-IgE omalizumab
- Reduction in asthma exacerbations
- Time to first asthma exacerbation
- Criteria for Omalizumab administration
- Blockbuster drug for asthma
- Self management effect on hospitalizations
- Effect of optimal self management on ED visits
- Asthma education and monitoring (1)
- Asthma education and monitoring (2)
- Asthma education
- Conclusions
- Acknowledgment
Topics Covered
- Importance of reviewing patient's history
- Identification of potential environmental factors
- Patients with uncontrolled asthma may require anti-inflammatory medications with inhaled corticosteroids (ICS) being the standard treatment
- Asthmatics on ICS with uncontrolled asthma may require adjunct therapy such as a long acting beta agonist and or a leukotriene antagonist
- Education program and written action plan
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Fitzgerald, M. (2013, January 31). The management of chronic asthma [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 11, 2021, from https://hstalks.com/bs/2487/.Publication History
Financial Disclosures
- Prof. Mark Fitzgerald has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.